Organovo CFO Jonathan Lieber resigns; Thomas P. Hess appointed as President and CFO

VivoSim Labs, INC.

Jonathan Lieber resigned effective Oct 6, 2021, to pursue a full-time opportunity; no disagreement with the Company.
Thomas P. Hess, age 57, appointed President, CFO and Principal Financial Officer, effective Oct 6, 2021, through Danforth Advisors at $400/hour.
At Oct 5, 2021 annual meeting, 45.91% of shares constituted quorum; Alison Tjosvold Milhous elected Class I director.
Stockholders ratified Mayer Hoffman McCann P.C. as auditor for FY2022 and approved advisory say-on-pay and amendment to 2012 Equity Incentive Plan.
Plan amended to increase share reserve to 2,327,699 shares and impose annual per-person limits of 400,000 shares and $2,000,000 cash.

item 5.02 item 5.07 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Thomas P. Hess

President, Chief Financial Officer and Principal Financial Officer

VIVS · VivoSim Labs, INC.

Effective: 2021-10-06
Filed: October 6, 2021, 7:59 PM ET

On October 6, 2021, the Company’s Board of Directors appointed Thomas P. Hess, age 57, as the Company’s newly appointed President, Chief Financial Officer and Principal Financial Officer, effective October 6, 2021, in connection with the resignation of Mr. Lieber.

Departed

Jonathan Lieber

President, Chief Financial Officer and Principal Financial Officer

VIVS · VivoSim Labs, INC.

Effective: 2021-10-06
Successor: Thomas P. Hess
Filed: October 6, 2021, 7:59 PM ET

On October 6, 2021, Jonathan Lieber, the President, Chief Financial Officer and Principal Financial Officer of Organovo Holdings, Inc. (the “Company”), notified the Company of his intent to resign, effective October 6, 2021, from his part-time role to pursue a full-time opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas P. Hess was appointed as President, Chief Financial Officer and Principal Financial Officer at VivoSim Labs, INC..

Action: appointed
Role: President, Chief Financial Officer and Principal Financial Officer

Exact text from the filing

On October 6, 2021, the Company’s Board of Directors appointed Thomas P. Hess, age 57, as the Company’s newly appointed President, Chief Financial Officer and Principal Financial Officer, effective October 6, 2021, in connection with the resignation of Mr. Lieber.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan Lieber resigned as President, Chief Financial Officer and Principal Financial Officer at VivoSim Labs, INC..

Action: resigned
Role: President, Chief Financial Officer and Principal Financial Officer

Exact text from the filing

On October 6, 2021, Jonathan Lieber, the President, Chief Financial Officer and Principal Financial Officer of Organovo Holdings, Inc. (the “Company”), notified the Company of his intent to resign, effective October 6, 2021, from his part-time role to pursue a full-time opportunity.

View on SEC.gov

VivoSim Labs, INC. filing history →

Source: SEC EDGAR

accession 0001564590-21-050320

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.